Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 2
2021 2
2022 6
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.
Niyomnaitham S, Jongkaewwattana A, Meesing A, Pinpathomrat N, Nanthapisal S, Hirankarn N, Siwamogsatham S, Kirdlarp S, Chaiwarith R, Lawpoolsri S, Phanthanawiboon S, Thitithanyanont A, Hansasuta P, Chaiyaroj S, Pitisuttithum P. Niyomnaitham S, et al. Among authors: pinpathomrat n. Int J Infect Dis. 2023 Apr;129:19-31. doi: 10.1016/j.ijid.2023.01.022. Epub 2023 Jan 20. Int J Infect Dis. 2023. PMID: 36682680 Free PMC article. Clinical Trial.
Regulatory T Cells Decreased during Recovery from Mild COVID-19.
Seepathomnarong P, Ongarj J, Sophonmanee R, Seeyankem B, Chusri S, Surasombatpattana S, Pinpathomrat N. Seepathomnarong P, et al. Among authors: pinpathomrat n. Viruses. 2022 Jul 30;14(8):1688. doi: 10.3390/v14081688. Viruses. 2022. PMID: 36016311 Free PMC article.
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population.
Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Kongkamol C, Ingviya T, Sangsupawanich P, Chusri S. Pinpathomrat N, et al. NPJ Vaccines. 2022 May 13;7(1):52. doi: 10.1038/s41541-022-00475-z. NPJ Vaccines. 2022. PMID: 35562372 Free PMC article.
Identification of antigens presented by MHC for vaccines against tuberculosis.
Bettencourt P, Müller J, Nicastri A, Cantillon D, Madhavan M, Charles PD, Fotso CB, Wittenberg R, Bull N, Pinpathomrat N, Waddell SJ, Stylianou E, Hill AVS, Ternette N, McShane H. Bettencourt P, et al. Among authors: pinpathomrat n. NPJ Vaccines. 2020 Jan 3;5(1):2. doi: 10.1038/s41541-019-0148-y. eCollection 2020. NPJ Vaccines. 2020. PMID: 31908851 Free PMC article.
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population.
Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Kongkamol C, Ingviya T, Sangsupawanich P, Chusri S. Pinpathomrat N, et al. NPJ Vaccines. 2022 Sep 6;7(1):107. doi: 10.1038/s41541-022-00529-2. NPJ Vaccines. 2022. PMID: 36068243 Free PMC article. No abstract available.
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine.
Sophonmanee R, Ongarj J, Seeyankem B, Seepathomnarong P, Intapiboon P, Surasombatpattana S, Uppanisakorn S, Sangsupawanich P, Chusri S, Pinpathomrat N. Sophonmanee R, et al. Among authors: pinpathomrat n. Vaccines (Basel). 2022 Sep 7;10(9):1494. doi: 10.3390/vaccines10091494. Vaccines (Basel). 2022. PMID: 36146571 Free PMC article.
20 results